Lillian Siu is a staff Medical Oncologist at Princess Margaret Hospital since 1998, and is a Professor at the University of Toronto. She is the Director of the Phase I Program and Co-Director of the Robert and Maggie Bras and Family Drug Development Program at Princess Margaret Hospital. Dr. Siu’s major research focus is in the area of new anticancer drug development, particularly with respect to phase I trials and head and neck malignancies. In 2009, she has been awarded a Cancer Care Ontario Chair in Experimental Therapeutics. In 2010, Dr. Siu was awarded by the US NCI the Michaele C.Christian Award in Oncology Drug Development. In addition, she is the principal investigator of the Princess Margaret Hospital Phase I Consortium, supported by a grant from the United States National Cancer Institute. Dr. Siu was the Chair for 2010 ASCO Grants Selection Committee, and is Co-Chair of the 2012 AACR Annual Meeting Program Committee. Dr. Siu has a strong interest in clinical trial methodology and has been one of the course directors of the ECCO/ASCO/AACR workshop in Flims, Switzerland. Dr. Siu has published over 120 peer-reviewed manuscripts and serves on the editorial board of Journal of Clinical Oncology, Cancer Discovery, European Journal of Cancer and Investigational New Drugs.